Patents by Inventor Peter Kotanko

Peter Kotanko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250079022
    Abstract: Techniques for patient population flow modeling are disclosed, where such modeling can provide insights for future trends among a patient population, e.g., to facilitate allocation of resources for the patient population or to inform treatment recommendations for patients. A flow model can be used on dialysis patient populations where the patients are grouped into a compartment according to a certain criterion (or given criteria), where each compartment corresponds to the number of patients in each group, and where the number of compartments can vary depending on the given criteria. A model can then be used to describe the transition rates between the different compartments, as well as influx and efflux within each compartment. Such a model can be used, by way of example, to investigate the impact of sodium-glucose co-transporter 2 (SGLT2) inhibitors on the population dynamics of end-stage renal disease patients.
    Type: Application
    Filed: November 16, 2024
    Publication date: March 6, 2025
    Inventors: Alhaji Cherif, Peter Kotanko, Nina Muellers, Zdenek Cerman, Julian Dreismeier, Robert Kossmann
  • Patent number: 12237084
    Abstract: A method for mitigating the spread of infectious diseases among dialysis patients is provided. The method comprises: receiving, by a prediction system and from a medical facility, individual treatment data indicating dialysis treatment information associated with a patient undergoing dialysis treatment; receiving, by the prediction system and from a blood testing laboratory, individual lab data indicating blood analysis information associated with the patient; determining, by the prediction system, disease analysis results for the patient based on inputting the individual treatment data and the individual lab data into a disease prediction machine learning (ML) model, wherein the disease analysis results indicate a likelihood of the patient being infected with a contagious disease; and providing, by the prediction system and to the medical facility, instructions indicating one or more responsive actions based on the disease analysis results.
    Type: Grant
    Filed: April 8, 2021
    Date of Patent: February 25, 2025
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Caitlin Kelly Monaghan, Peter Kotanko, John Larkin, Jeffrey Hymes, Kathleen Belmonte, Len Usvyat, Ines A. Dahne-Steuber, Franklin W. Maddux
  • Patent number: 12228564
    Abstract: An apparatus used in analyzing spent dialysate includes at least a first surface configured to accommodate a dialysate drain bag in a first predetermined position, and at least a second surface configured to accommodate a dialysate analysis device in a second predetermined position, such that when the dialysate drain bag is in the first predetermined position and the dialysate analysis device is in the second predetermined position, a light sensor of the dialysate analysis device is positioned to sense light passing through the dialysate drain bag.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: February 18, 2025
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Peter Kotanko, Xia Tao, Mia G. Garbaccio, Stephan Thijssen, Nadja Grobe, Leticia M. Tapia Silva
  • Patent number: 12226563
    Abstract: Techniques for vascular access identification and validation are disclosed. The techniques include: directly or indirectly acquiring an acquired value for a parameter that is a function of oxygen saturation (SO2) of a sample of blood in or obtained from a vascular access device (VAD) disposed in a subject; performing an evaluation of the acquired value at least by comparing the acquired value with one or more reference values; and responsive to the evaluation of the acquired value, assigning an identity classification to the VAD, wherein the identity classification is one of a central venous catheter (CVC), an arteriovenous access device (AVA), or another class of VAD.
    Type: Grant
    Filed: November 6, 2020
    Date of Patent: February 18, 2025
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Peter Kotanko, Stephan Thijssen, Anna Meyring-Wösten, Hanjie Zhang
  • Patent number: 12230403
    Abstract: The described technology may include processes to model acid-base homeostasis in normal patients and under acid-base disorder conditions. In one embodiment, a method may include an acid-base homeostasis analysis. The method may include, via a processor of a computing device: providing a physiological acid-base model configured to model acid-base homeostasis of a virtual patient, the physiological acid-base model to: determine a plurality of operating parameters for an HCO3/CO2 buffering system having renal and pulmonary regulatory mechanisms, determine acid-base information comprising a bicarbonate concentration, a carbon dioxide concentration, and a free hydrogen ions concentration via simulating the HCO3/CO2 buffering system, and determine predicted patient information based on the acid-base information. Other embodiments are described.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: February 18, 2025
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Alhaji Cherif, Peter Kotanko, Doris Helen Fuertinger
  • Publication number: 20250054600
    Abstract: This disclosure teaches the generation of multiple recipes for patients with chronic kidney disease. The recipes are generated by application of a large language model to patient data, including both medical and preference data. The recipes are verified by a dietician and may be used to generate shopping lists and instructions for an automated food preparation device.
    Type: Application
    Filed: August 8, 2024
    Publication date: February 13, 2025
    Applicant: Fresenius Medical Care Holdings Inc.
    Inventors: Peter Kotanko, Hanjie Zhang, Lin-Chun Wang, Ulrike Kotanko, Nancy Ginsberg
  • Publication number: 20240428904
    Abstract: Techniques and apparatus for generating, performing, and evaluating virtual clinical trials that include clinic modules to represent real-world operational aspects of trial entities are described. In one embodiment, for example, an apparatus may include at least one memory, and logic coupled to the at least one memory. The logic may be configured to generate a plurality of avatars configured to model a health condition associated with a population of patients, and to perform a virtual clinical trial to simulate a course of treatment for the plurality of avatars, the virtual clinical trial to include at least one clinic module associated with at least one event and a probability for the at least one event, the at least one event to model an operational aspect of an entity of the virtual clinical trial. Other embodiments are described.
    Type: Application
    Filed: September 4, 2024
    Publication date: December 26, 2024
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Doris H. Fuertinger, Alice Topping, Franz Kappel, Stephan Thijssen, Peter Kotanko
  • Publication number: 20240374158
    Abstract: The present teachings generally include devices, systems, methods, and computer-program products for determining a fluid status of patients using bioimpedance measurements and the like. In general, aspects of the present teachings may include one or more of: an eight-point electrode bioimpedance device including two (wired or wireless) handles with integrated sensors to measure distance, e.g., so that body height and segmental length can be measured; techniques to determine the fluid status of a patient from bioimpedance measurements of the patient's legs; improved techniques for determining fluid overload (or otherwise determining fluid status) using a ratio of extracellular volume (ECV) to total body water (TBW); and using body segmental resistances to determine fluid status and/or fluid volume.
    Type: Application
    Filed: May 2, 2024
    Publication date: November 14, 2024
    Inventors: Fansan Zhu, Peter Kotanko
  • Publication number: 20240331866
    Abstract: Techniques for real-time intradialytic hypotension (IDH) prediction are disclosed. A system obtains historical hemodialysis treatment data that is segmented into sets of machine learning training data based on temporal proximities to IDH events and trains a machine learning model to predict IDH events based on the sets of machine learning training data.
    Type: Application
    Filed: June 11, 2024
    Publication date: October 3, 2024
    Inventors: Peter Kotanko, Hanjie Zhang
  • Patent number: 12106831
    Abstract: Techniques and apparatus for generating, performing, and evaluating virtual clinical trials that include clinic modules to represent real-world operational aspects of trial entities are described. In one embodiment, for example, an apparatus may include at least one memory, and logic coupled to the at least one memory. The logic may be configured to generate a plurality of avatars configured to model a health condition associated with a population of patients, and to perform a virtual clinical trial to simulate a course of treatment for the plurality of avatars, the virtual clinical trial to include at least one clinic module associated with at least one event and a probability for the at least one event, the at least one event to model an operational aspect of an entity of the virtual clinical trial. Other embodiments are described.
    Type: Grant
    Filed: February 10, 2022
    Date of Patent: October 1, 2024
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Doris H. Fuertinger, Alice Topping, Franz Kappel, Stephan Thijssen, Peter Kotanko
  • Publication number: 20240316254
    Abstract: Techniques for monitoring fluid volumes during peritoneal analysis include: computing lower abdominal fluid volumes, continuously during a dwell time of a peritoneal dialysis treatment, based at least on bioimpedance data from electrodes positioned on a patient's upper thighs; and computing intraperitoneal volumes, continuously during the dwell time of the peritoneal dialysis treatment, based at least on bioimpedance data from the electrodes positioned on the patient's upper thighs and electrodes positioned on the patient's torso.
    Type: Application
    Filed: June 4, 2024
    Publication date: September 26, 2024
    Inventors: Peter Kotanko, Fansan Zhu
  • Publication number: 20240316253
    Abstract: An apparatus used in analyzing spent dialysate includes: at least one surface configured to accommodate a dialysate drain bag or drain line in a predetermined position; a light source positioned to emit light through the dialysate drain bag or drain line; and a light sensor positioned to sense light emitted by the light source through the dialysate drain bag or drain line.
    Type: Application
    Filed: June 4, 2024
    Publication date: September 26, 2024
    Inventors: Peter Kotanko, Xia Tao, Mia G. Garbaccio, Jeffrey Hymes, Stephan Thijssen, Nadja Grobe, Leticia M. Tapia Silva, Dinesh K. Chatoth
  • Patent number: 12090257
    Abstract: A method for detecting occult hemorrhages is provided. The method includes obtaining a first hematocrit concentration prior to infusing a saline solution into a bloodstream of a patient. The method further includes infusing the saline solution into the bloodstream of the patient and obtaining a second hematocrit concentration after infusing the saline solution into the bloodstream. The method also includes determining a first absolute blood volume based on the first hematocrit concentration and the second hematocrit concentration. In addition, the method includes generating a notification indicating a potential occult hemorrhage based on the first absolute blood volume and a pre-defined absolute blood volume threshold, and providing the notification indicating the potential occult hemorrhage.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: September 17, 2024
    Assignees: Fresenius Medical Care Deutschland GmbH, Fresenius Medical Care Holdings, Inc.
    Inventors: Sabrina Casper, Peter Kotanko
  • Patent number: 12076472
    Abstract: Techniques for monitoring fluid volumes during peritoneal analysis include: computing lower abdominal fluid volumes, continuously during a dwell time of a peritoneal dialysis treatment, based at least on bioimpedance data from electrodes positioned on a patient's upper thighs; and computing intraperitoneal volumes, continuously during the dwell time of the peritoneal dialysis treatment, based at least on bioimpedance data from the electrodes positioned on the patient's upper thighs and electrodes positioned on the patient's torso.
    Type: Grant
    Filed: October 9, 2020
    Date of Patent: September 3, 2024
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Peter Kotanko, Fansan Zhu
  • Patent number: 12046375
    Abstract: A computing system for determining a systematic training strategy for the user is provided. The computing system includes a user device that uses one or more sensors to obtain partial pressure of oxygen (PO2) levels of a user over a period of time. The user device provides previous PO2 levels to a personalized erythropoiesis model generation computing platform. The computing platform obtains individualized user data for the user indicating or more previous hematocrit and/or hemoglobin measurements for the user. The computing platform determines an individualized erythropoiesis model for the user based on the one or more previous hematocrit and/or hemoglobin measurements and the previous PO2 information, and employs the individualized erythropoiesis model to determine predicted hematocrit and/or hemoglobin measurements. The computing platform performs one or more actions based on the one or more predicted hematocrit and/or hemoglobin measurements.
    Type: Grant
    Filed: October 5, 2022
    Date of Patent: July 23, 2024
    Assignees: Fresenius Medical Care Holdings, Inc., Fresenius Medical Care Deutschland GmbH
    Inventors: Peter Kotanko, Ulrike Kotanko, Sabrina Casper, David Joerg, Gudrun Schappacher-Tilp, Doris Fuertinger
  • Patent number: 12036344
    Abstract: An apparatus used in analyzing spent dialysate includes: at least one surface configured to accommodate a dialysate drain bag or drain line in a predetermined position; a light source positioned to emit light through the dialysate drain bag or drain line; and a light sensor positioned to sense light emitted by the light source through the dialysate drain bag or drain line.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: July 16, 2024
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Peter Kotanko, Xia Tao, Mia G. Garbaccio, Jeffrey Hymes, Stephan Thijssen, Nadja Grobe, Leticia M. Tapia Silva, Dinesh K. Chatoth
  • Patent number: 12040092
    Abstract: Techniques for real-time intradialytic hypotension (IDH) prediction are disclosed. A system obtains historical hemodialysis treatment data that is segmented into sets of machine learning training data based on temporal proximities to IDH events and trains a machine learning model to predict IDH events based on the sets of machine learning training data.
    Type: Grant
    Filed: June 10, 2020
    Date of Patent: July 16, 2024
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Peter Kotanko, Hanjie Zhang
  • Publication number: 20240216596
    Abstract: The present disclosure relates to a medical functional device or arrangement of components having a first blood circuit for extracorporally withdrawing and reintroducing blood from and to a patient (P), and a second blood circuit for extracorporally withdrawing and reintroducing blood from and to a person (D), wherein both the first blood circuit and the second blood circuit each comprise an arterial line and a venous line. In this, the medical functional device, or the arrangement, comprises at least one connecting device for establishing a fluid communication between the arterial line of the first blood circuit for the patient (P) with the venous line (73) of the second blood circuit for the person (D) and for establishing a fluid communication between the arterial line of the second blood circuit for the person (D) with the venous line of the first blood circuit for the patient (P).
    Type: Application
    Filed: December 22, 2022
    Publication date: July 4, 2024
    Inventors: Peter Kotanko, Dejan Nikolic, Alexander Heide
  • Publication number: 20240127961
    Abstract: A method for determining a next hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) dosage for a first patient using a patient HIF-PHI model is provided. The method includes obtaining population patient data indicating HIF-PHI dosages and hemoglobin measurements for the patients. Then, virtual patient avatars are generated based on the population patient data. Each of the virtual patient avatars indicates a set of personalized model parameters for a HIF-PHI model. A plurality of HIF-PHI models are determined for the virtual patient avatars. Using the HIF-PHI models, one or more HIF-PHI treatment schemes for administering the HIF-PHI dosages is determined. Subsequently, the HIF-PHI treatment schemes along with a hematocrit and/or hemoglobin concentration for a patient are used to determine a next HIF-PHI dosage for the patient, and the next HIF-PHI dosage is administered for the patient.
    Type: Application
    Filed: October 5, 2022
    Publication date: April 18, 2024
    Inventors: Doris Fuertinger, David Joerg, Gudrun Schappacher-Tilp, Peter Kotanko
  • Publication number: 20240127962
    Abstract: A computing system for determining a systematic training strategy for the user is provided. The computing system includes a user device that uses one or more sensors to obtain partial pressure of oxygen (PO2) levels of a user over a period of time. The user device provides previous PO2 levels to a personalized erythropoiesis model generation computing platform. The computing platform obtains individualized user data for the user indicating or more previous hematocrit and/or hemoglobin measurements for the user. The computing platform determines an individualized erythropoiesis model for the user based on the one or more previous hematocrit and/or hemoglobin measurements and the previous PO2 information, and employs the individualized erythropoiesis model to determine predicted hematocrit and/or hemoglobin measurements. The computing platform performs one or more actions based on the one or more predicted hematocrit and/or hemoglobin measurements.
    Type: Application
    Filed: October 5, 2022
    Publication date: April 18, 2024
    Inventors: Peter Kotanko, Ulrike Kotanko, Sabrina Casper, David Joerg, Gudrun Schappacher-Tilp, Doris Fuertinger